Matthew D. Silverman

Special Counsel

+1 858 550 6152
msilverman@cooley.com

Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.

Download full bio 

Experience

  • IonQ Agrees to SPAC Merger With dMY Technology Group III 

  • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 

  • Horizon Therapeutics to Acquire Viela Bio 

  • Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion 

  • Sunrun to Acquire Vivint Solar for Enterprise Value of $3.2 Billion 

  • View all

Practices & Industries

Passions

    Film, Music, Surfing and Travel

Education

  • Fordham University School of Law
    JD, cum laude, 2012

  • University of Vermont
    BA, Economics and Political Science
    Honors Program, 2006


Admissions & Credentials

California

New York

contact

+1 858 550 6152 office
msilverman@cooley.com

4401 Eastgate Mall
San Diego, CA 92121-1909